Cost-Effectiveness of School-Based Prevention of Cannabis Use
Abstract
Background Cannabis is the most frequently used illicit drug globally. Despite increasing evidence that cannabis use is associated with adverse health effects, the knowledge on preventative strategies is still limited. This study stemmed from a systematic review of effective prevention in which school-based programmes were identified as promising. The primary objective was to evaluate the cost effectiveness of Project ALERT (Adolescent, Learning, Experiences, Resistance, and Training), compared with ordinary ATOD (Alcohol, Tobacco, and Other Drug) education, among Swedish students in the eighth grade of compulsory school. Methods The cost-effectiveness analysis was performed from the societal perspective with quality-adjusted life-years (QALYs) as an outcome (willingness-to-pay threshold €50,000) and follow-up periods from 1 year to a lifetime, considering a discounting rate of 3%, and with costs inflated to 2013 levels. A Markov model was constructed on the basis of the 'states' of single use, regular use, daily use and use of other illicit drugs, which were associated with 'complications' of psychosis, schizophrenia, traffic accidents, depression and amotivational syndrome. Health and cost consequences were linked to both states and complications. Results The programme was cost saving on the basis of evidence from the USA (ratio 1:1.1), and was cost effective (incremental cost-effectiveness ratio €22,384 per QALY) after reasonable adjustment for the Swedish context and with 20 years of follow-up. When the target group was restricted to boys who were neither studying nor working/doing work experience, the programme was cost effective after 9 years and cost saving (ratio 1:3.2) after 20 years. Conclusion School-based prevention such as Project ALERT has the potential to be cost effective and to be cost saving if implemented in deprived areas. In the light of the shifting landscape regarding legalization of cannabis, it seems rational to continue the health economic analysis of prevention initiated here.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
This review is the first international review to comprehensively bring together economic evaluations of preventive interventions specifically for opioid misuse, cannabis and illicit drug use.
“This review is the first international review to comprehensively bring together economic evaluations of preventive interventions specifically for opioid misuse, cannabis and illicit drug use.”
From A systematic review of economic evaluations for opioid misuse, cannabis and illicit drug use prevention (2023) · cites this paper as [15]
Cites
A Systematic Review of the Prevalence of Schizophrenia
Saha, S., Chant, D., Welham, J., & McGrath, J. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020141 · Cited by 2,168 · see citing works
Swedish population health-related quality of life results using the EQ-5D
Burström, K., Johannesson, M., & Diderichsen, F. (2001) · Quality of Life Research · doi:10.1023/a:1013171831202 · Cited by 664 · see citing works
Briggs, A., Wild, D., Lees, M., Reaney, M., Dursun, S., Parry, D., & Mukherjee, J. (2008) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-6-105 · Cited by 122 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Faller, J., Le, L. K.-D., Chatterton, M. L., Perez, J. K., Chiotelis, O., Tran, H. N. Q., Sultana, M., Hall, N., Lee, Y. Y., Chapman, C., et al. (2023) · BJPsych Open · doi:10.1192/bjo.2023.515 · Cited by 6 · see citing works
- Authors
- Deogan, C., Zarabi, N., Stenström, N., Högberg, P., Skärstrand, E., Manrique-Garcia, E., Neovius, K., & Månsdotter, A.
- Affiliations
- Karolinska Institutet (SE)
- National Board of Health and Welfare (SE)
- Public Health Agency of Sweden (SE)
- Corresponding author
- Månsdotter, Anna
- Venue
- Applied Health Economics and Health Policy
- Published
- 2015-05-14
- Volume
- 13
- Issue
- 5
- Pages
- 525-542
- ISSN
- 1175-5652 (ISSN-L)
- 1179-1896
- OpenAlex
- W221856338
- Cited by
- 20
- References
- 3
- Citations by year
- 2026: 3 · 2025: 1 · 2024: 4 · 2023: 2 · 2021: 3 · 2020: 3 · 2018: 1 · 2017: 1 · 2016: 1 · 2015: 1
- FWCI
- 1.05
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Applied Health Economics and Health Policy (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Health Sciences › Medicine › Physiology › Smoking Behavior and Cessation
- Keywords
- cannabis use prevention, school-based prevention, Project ALERT, cost-effectiveness, quality-adjusted life years, adolescent substance use, Markov model, psychosis, traffic accidents, amotivational syndrome, cannabis legalization, underserved areas
- MeSH terms
- Adolescent, Adult, Age Factors, Aged, Aged, 80 and over, Marijuana Abuse, Cost-Benefit Analysis, Female, Humans, Male, Middle Aged, School Health Services, Sweden, Health Care Costs, Models, Economic, Quality-Adjusted Life Years, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review